|
Federal Interagency Workshop: Nonhuman Primate Resources and Needs for Biomedical Research
|
Meeting/ Workshop
|
BARDA
|
OD/DPCPSI/ORIP
|
This Federal Interagency Workshop was hosted by the NIH-Wide Nonhuman Primate Resource Planning Working Group. The meeting was held March 22, 2022, in response to a recommendation of the Expert Panel forum, entitled; Challenges in Assessing Nonhuman Primate Needs and Resources for Biomedical Research, held August 23-24, 2018. A non-public Final Report of the 2022 Federal Interagency Workshop was also developed.
|
|
Federal Partners in Bullying Prevention
|
Committee, Work group, Advisory group, or Task Force
|
ACF, CDC, HRSA, IHS, SAMHSA
|
NIAAA, NICHD, NIMH, OD/DPCPSI/OBSSR
|
The mission of the Federal Partners in Bullying Prevention is to provide information from a broad array of government agencies on the identification and prevention of and ways to respond to bullying and cyberbullying, as well as individuals most at risk to experience it. https://www.stopbullying.gov/about-us
|
|
Federal Plan for Equitable Long-Term Recovery and Resilience
|
Committee, Work group, Advisory group, or Task Force
|
OASH, ATSDR, CDC, FDA, HRSA, SAMHSA
|
OD/DPCPSI/ODS
|
The Federal Plan for Equitable Long-Term Recovery and Resilience (Federal Plan for ELTRR) was developed by the ELTRR Interagency Workgroup with active, sustained, and consistent engagement. The interagency body was formed in early 2020 in response to a specific objective in the federal government’s joint COVID-19 response.Senior career professionals from over 35 federal departments and agencies collaborated to develop the Plan. The number of departments and agencies engaged in the workgroup continues to grow.
|
|
Federal Substance-Exposed Pregnancies Working Group
|
Committee, Work group, Advisory group, or Task Force
|
ACF, AHRQ, ASPE, CMS, FDA, HRSA, IHS, OASH, OS
|
NIDA
|
Keep up to date with federal efforts related to Neonatal Abstinence Syndrome (NAS) and Neonatal Opioid Withdrawal Syndrome (NOWS).
|
|
Federal Supply and Demand of Isotopes
|
Committee, Work group, Advisory group, or Task Force
|
FDA
|
NCI, NIBIB
|
A workshop on Isotope Federal Supply and Demand is held annually. The workgroup that organizes this workshop consists of representatives of federal agencies with the aim of providing a forum for interaction between agencies, departments, and medical societies to communicate about potential shortages of isotopes that are of strategic importance to the nation including the availability of medical isotopes. Also, a report of isotope supply and demand and whether needs are commercially available is compiled by the National Institutes of Health (NIH) and submitted to DOE annually. The report includes demand for NIH intramural research programs and NIH extramural projects (grantees). Not included in this report are NIH intramural research needs that are supplied by its cyclotron or isotope needs to be met by commercial suppliers. NIH collects data from ICs and submits annual reports as required. On January 12, 2021, DOE, NIH, and the members of the Isotope Needs Program held the 7th Workshop on Isotope Federal Supply and Demand. The meeting reviewed the Program’s ongoing activities and reported that the newly evolving use of electron- and alpha-emitting isotopes are seeing increased need (based on FDA’s approval for medical applications); the DOE is developing a plan to meet the current and foreseen increased use of these isotopes for cancer therapy. In support of these efforts, NIBIB conducted an August 16-17, 2021, workshop that focused on instrumentation development to directly image these new electron- and alpha-emitting isotopes for enhancing cancer therapy outcomes.
|
|
Federal Web Archiving Interest Group
|
Committee, Work group, Advisory group, or Task Force
|
ASPA
|
NLM
|
The Federal Web Archiving Interest Group focuses on sharing strategies, workflows, and best practices for collecting, preserving, and providing access to archived web content of interest to U.S. federal agencies. As needed, smaller working groups may form to advance joint projects. The main goal for this interest group is to provide a space for discussing current and future projects, collaboration, and mutual support of web archiving efforts across the federal government and to avoid unnecessary duplication of effort. https://siarchives.si.edu/about/partnerships/fedweb
|
|
Federal Working Group on Bone Diseases (FWGBD)
|
Committee, Work group, Advisory group, or Task Force
|
CDC, CMS, FDA
|
NIA, NIAMS, OD/DPCPSI/ORWH
|
An interagency committee focusing on osteoporosis and other bone disorders. It offers a forum for sharing information, learning from each other and invited speakers, and facilitating the development, early in the planning stages, of collaborative research activities based on each agency's mission.
|
|
Federated learning across Health Information Exchanges (HIE)
|
Committee, Work group, Advisory group, or Task Force
|
ONC
|
NCI
|
In cooperation with the Nebraska Health Information Initiative (NEHII) and the National Cancer Institute (NCI), NIH launched a pilot program earlier this year that uses a machine learning concept known as federated learning that could leverage existing HIE data while ensuring privacy. Federated learning is a machine learning technique that shares an analytical model between different groups, allowing them to analyze their own data – and share those results – without needing to share the actual raw data.The pilot aimed to expand clinical insights regarding COVID-19 using the existing ways health data are stored and protected in the US. In our pilot, each organization connected to a central cloud ecosystem known as the Multi-state Federated Architecture for Shared Analytics, better known as MuFASA.
|
|
Federated Linked Data System Working Group
|
Committee, Work group, Advisory group, or Task Force
|
CDC, CMS, FDA, OS
|
NCI
|
Provide feedback and guidance for the legal and governance framework of a federated linked data system
|
|
Fellowship in Genomic Science and Health Equity
|
Training Initiative
|
FDA
|
NHGRI
|
The FDA's Office of Minority Health and Health Equity and the NHGRI jointly sponsor a fellowship program for masters and postdoctoral level scholars to provide training in genetic, genomic, and pharmacogenomic approaches to advance minority health and health equity. Working closely with mentors at both the FDA and NIH, this program helps fellows learn to bridge research, development and review processes, advance their knowledge of health disparities, and build awareness of regulatory sciences.
|